Lemborexant

Back to search

Molecule Structure

Scientific Name

Lemborexant

Description of the Drug

Lemborexant is a dual orexin antagonist indicated for the treatment of sleep-onset and/or sleep maintenance insomnia.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11951

Brand Name(s)

Dayvigo

Company Owner(s)

Eisai Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Orexin receptor 1 SINGLE PROTEIN ANTAGONIST CHEMBL5113
Orexin receptor 2 SINGLE PROTEIN ANTAGONIST CHEMBL4792

Unichem Links

SureChEMBL SCHEMBL2116558
DrugBank DB11951
PubChem: Thomson Pharma 135646445
PubChem 56944144
Nikkaji J3.610.985H
PDBe NRK
BindingDB 50093793
DrugCentral 5360
ChemicalBook CB72744022
Guide to Pharmacology 9302
rxnorm DAYVIGO LEMBOREXANT
ZINC ZINC000118073503